Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01576640 · ClinicalTrials.gov registry record · Phase 4
Extended Duration Nicotine Replacement Therapy and Bupropion in Smokers With Schizophrenia
A Phase 4 study, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- Phase 4
- Development phase
- 17
- Enrollment target
NCT01576640: Clinical Trial Phase 4 study, sponsored by Massachusetts General Hospital.
NCT01576640 is a Phase 4 study that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01576640, a Phase 4 study, was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 17 participants
- Enrollment target
Study Summary
After successfully quitting smoking, smokers with schizophrenia are vulnerable to relapse shortly after discontinuation of treatment. The purpose of this study was to assess the feasibility and effectiveness of a 12-month relapse prevention intervention in recently abstinent smokers with schizophrenia. Subjects participated in a 12-week smoking cessation phase, where they received nicotine replacement therapy, bupropion SR 150mg bid, and cognitive behavioral therapy. If, at the end of the 12 weeks, they were able to demonstrate 1 week of abstinence, they continued in the relapse prevention phase of the study, where they continued to receive nicotine replacement therapy, bupropion SR 150mg bid, and cognitive behavioral therapy.
Interventions
- DRUG NRT
- DRUG Bupropion SR 150mg bid
- OTHER Relapse Prevention-Oriented Cognitive Behavioral Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2005-12 |
| Est. Completion | 2007-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01576640
The ClinicalTrials.gov registry entry for NCT01576640 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which NRT is the first listed.
NCT01576640 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01576640 about?
NCT01576640 is a clinical study titled "Extended Duration Nicotine Replacement Therapy and Bupropion in Smokers With Schizophrenia". After successfully quitting smoking, smokers with schizophrenia are vulnerable to relapse shortly after discontinuation of treatment. The purpose of this study was to assess the feasibility and effectiveness of a 12-month relapse prevention intervention in recently abstinent smokers with schizophren...
What is the current status of trial NCT01576640?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 17 participants. The study started on 2005-12. Estimated completion is 2007-10.
What interventions are being tested in trial NCT01576640?
The interventions under investigation include: NRT (DRUG), Bupropion SR 150mg bid (DRUG), Relapse Prevention-Oriented Cognitive Behavioral Therapy (OTHER).
Who is sponsoring clinical trial NCT01576640?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.